Effect of the novel dual orexin receptor antagonist daridorexant on night-time respiratory function and sleep in patients with moderate chronic obstructive pulmonary disease.

Author: BoofMarie-Laure, BrunkeMareile, DingemanseJasper, EsselmannAlbert, FietzeIngo, HeymerPeter, KestermannOlaf, LedererKatharina, UferMike

Paper Details 
Original Abstract of the Article :
In patients with chronic obstructive pulmonary disease (COPD), sleep is often fragmented while, conversely, the use of sleep medications is of concern in these patients due to potential impairment of nocturnal breathing. This randomised, double-blind, placebo-controlled, two-period crossover study w...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1111/jsr.13248

データ提供:米国国立医学図書館(NLM)

Daridorexant: A New Approach to Sleep and Respiratory Function in COPD

Chronic obstructive pulmonary disease (COPD) can be a debilitating condition, like a desert storm that disrupts breathing and sleep. This study explores the potential of daridorexant, a new dual orexin receptor antagonist, to improve night-time respiratory function and sleep in patients with moderate COPD. The researchers are like skilled desert guides, seeking a path that eases the burden of COPD and restores restful sleep.

A New Oasis: Daridorexant for Sleep and Respiratory Function

This study investigates the potential of daridorexant to improve sleep and respiratory function in patients with COPD, hoping to find a safe and effective way to alleviate the symptoms of this condition. The researchers found that daridorexant did not impair night-time respiratory function and improved sleep parameters, suggesting that it may offer a valuable new approach to managing the challenges of COPD. It's like finding a well-maintained path through the dunes, leading to a more restful and comfortable experience. They are seeking a path that leads to a calmer and more restful experience for patients with COPD.

A Promising Path: Exploring New Treatments for COPD

This research is a testament to the ongoing efforts to find effective treatments for COPD, much like a caravan searching for a better route through the dunes. The study's findings suggest that daridorexant could be a valuable tool in the fight against COPD, offering a potentially safer and more effective path for patients. This is a hopeful development in the desert of COPD treatment, providing a potential solution for those who are struggling with this condition.

Dr. Camel's Conclusion

Daridorexant is a promising new oasis in the desert of COPD treatment, offering a potential path to better sleep and respiratory function. It's like finding a shortcut through the dunes, saving time and resources while still achieving the desired outcome. This research is a testament to the continuous progress being made in medical technology, providing new and innovative solutions to health challenges. It's a reminder that even in the vast and challenging desert of medical research, there is always hope for a better tomorrow.

Date :
  1. Date Completed 2021-09-28
  2. Date Revised 2021-09-28
Further Info :

Pubmed ID

33417730

DOI: Digital Object Identifier

10.1111/jsr.13248

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.